Back

Validation of an AI‑ECG tool to detect left ventricular systolic dysfunction in community-based patients with suspected heart failure and elevated NT‑proBNP.

31 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: HFrEF therapy: beyond current standards Heart Failure with Reduced Ejection Fraction (HFrEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Usmaan Razzaq

Queen Elizabeth University Hospital, Glasgow (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Effect of traditional Chinese medicine Qiliqiangxin in patients With HFrEF treated with sacubitril/valsartan: the QUEST trial
Doctor I. Cheang (Nanjing, CN)
Abstract Slides Video
Presentation thumbnail
Integrating six-minute walk distance into a simple multimarker score improves risk stratification in advanced HFrEF
Doctor M. Chudy (Bratislava, SK)
Abstract Slides Video
Presentation thumbnail
Multicentre validation of an AI model for detection of reduced left ventricular ejection fraction
Mr R. Rama (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
NT-proBNP and UACR for outcome prediction in HFrEF
Doctor N. Panagiotides (Vienna, AT)
Abstract Slides Video
Presentation thumbnail
Effects of sacubitril/valsartan versus enalapril on NT-proBNP and hs-troponin T in patients with heart failure due to Chagas disease: insights from the PARACHUTE-HF trial
Doctor L. Echeverria (Floridablanca, CO)
Abstract Slides Video

Access the full session

Session thumbnail
HFrEF therapy: beyond current standards

The Event

Event poster

ESC Congress 2026

31 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
Implementing an AI-ECG based algorithm to screen for left ventricular dysfunction in Kenya: a prospective cohort study
17 May 2025
thumbnail
Congress Presentation
External validation, robustness, and clinical error profiling of a multimodal electrocardiogram model for structural heart disease reveals a dominant shared prediction component
30 August 2026
thumbnail
Congress Presentation
Diagnostic accuracy and clinical utility of AI-assisted transthoracic echocardiography for detecting left ventricular systolic dysfunction: a meta-analysis and diagnostic test accuracy
31 August 2026
thumbnail
Congress Presentation
AI-driven echocardiographic phenotyping in patients with heart failure – A help to identify amyloidosis and aortic stenosis in real word hospital cohorts
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources